-2 Market Share

On the basis of geographical analysis, the global congenital anomalies treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific industry is predicted to account for largest revenue share by 2037, on the back of advancements in the healthcare sector, and rising healthcare expenditure across the region.

The market in the North America region is anticipated to gain the largest congenital anomalies treatment market share throughout the forecast period owing to the high prevalence of congenital diseases in infants in the region. As per the data by the Center of Disease Control and Prevention (CDC), one in every 33 babies or about 3% of all babies born in the United States suffer from birth defects each year.